VANCE trial marks milestone in t cell therapy for solid tumors

Cell News

VANCE trial marks milestone in t cell therapy for solid tumors
Clinical TrialImmunotherapyBiomarker
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 50 sec. here
  • 22 min. at publisher
  • 📊 Quality Score:
  • News: 93%
  • Publisher: 71%

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

SingHealthNov 11 2024 Led by a Singapore clinician-scientist, the multinational, phase III VANCE trial demonstrates that Singapore has the expertise and capabilities to run a large-scale global cell therapy trial. Results were published in the high impact factor journal, Annals on Oncology , in October 2024.

"This international T cell therapy trial driven by Singapore's biotech and the National Cancer Centre Singapore represents a significant milestone. The delivery of high-quality T cells at large scale has been a major barrier for extending the applications of these therapies.

There have been efforts to find more effective treatments for advanced NPC. NPC is closely associated with the Epstein-Barr virus , making NPC a good candidate to treat with immunotherapy targeting EBV. Small studies have shown that EBV-specific cytotoxic T cell therapy, a type of T cell therapy, produces clinical responses and clinical benefit in NPC patients.

Related StoriesA total of 330 patients were enrolled between July 2014 and January 2020 at 23 trial sites in Singapore, Malaysia, Thailand, Taiwan and the United States. Participants were randomly divided into two groups – one that received chemotherapy followed by EBV-CTL therapy, and one that received chemotherapy alone.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Clinical Trial Immunotherapy Biomarker Blood Cancer Carboplatin Carcinoma Chemotherapy Epstein-Barr Virus Gemcitabine Hospital Immune System Laboratory Manufacturing Medicine Nasopharyngeal Oncology Proton Therapy Research Virus

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Northern Ireland: Marissa Callaghan and Demi Vance left out of squad for Euro 2025 play-offNorthern Ireland: Marissa Callaghan and Demi Vance left out of squad for Euro 2025 play-offMarissa Callaghan and Demi Vance are not been included in Northern Ireland's squad for next week's Euro 2025 play-off with Croatia.
Read more »

Vance Calls Russia an American Adversary But Won’t Label Moscow an EnemyVance Calls Russia an American Adversary But Won’t Label Moscow an EnemyVance also said Trump is committed to NATO, the transatlantic military alliance seen as the bulwark preventing further Russian aggression.
Read more »

Harris Campaign Highlights J.D. Vance’s Ties to Commentator CNN Pulled for On-Air ‘Racism’Harris Campaign Highlights J.D. Vance’s Ties to Commentator CNN Pulled for On-Air ‘Racism’Ryan Girdusky, a political consultant with ties to J.D. Vance, was banned by CNN after likening a pro-Palestinian fellow panelist to a terrorist.
Read more »

Vance wrongly blames rural hospital closures on immigrants in the country illegallyVance wrongly blames rural hospital closures on immigrants in the country illegallyDuring a recent presidential campaign rally in Wisconsin, Sen. JD Vance (R-Ohio) was asked how a Trump administration would protect rural health care access in the face of hospital closures, such as two this year in Eau Claire and Chippewa Falls.
Read more »

JD Vance in New Hampshire SundayJD Vance in New Hampshire SundaySen. JD Vance is set to hold a rally in Derry, New Hampshire, Sunday, Donald Trump's campaign announced.
Read more »

JD Vance holding rally in New Hampshire SundayJD Vance holding rally in New Hampshire SundaySen. JD Vance is set to hold a rally in Derry, New Hampshire, Sunday, Donald Trump's campaign announced.
Read more »



Render Time: 2025-02-19 20:48:34